Sobi and Sanofi Renew Commitment to Hemophilia Care for Five More Years

Strengthened Support for Hemophilia Patients

In a remarkable display of commitment to global health, Sobi® (STO: SOBI) and Sanofi, through their philanthropic branch Foundation S, have extended their partnership with the World Federation of Hemophilia (WFH). This renewed agreement spans up to five years and is set to significantly bolster the WFH Humanitarian Aid Program, primarily focusing on providing essential medicine donations and financial assistance to those suffering from hemophilia.

In an official announcement made in Stockholm, the organizations revealed that they would donate up to 100 million international units (IU) of factor therapy annually. These contributions will be channeled through the WFH Humanitarian Aid Program, aiding individuals in developing countries who grapple with inherited bleeding disorders. The ongoing support reflects a legacy that has been in motion for over a decade, demonstrating the unwavering resolve of all parties involved to enhance the quality of care for hemophilia patients worldwide.

A Long-Standing Commitment

This partnership's significance is underscored by the successful history shared over the past ten years. Since their initial pledge, Sobi and Sanofi have collectively donated an astonishing one billion IUs of treatment products. These contributions have enabled the successful treatment of 22,219 individuals battling inherited bleeding disorders, encapsulating the tangible impact of their joint efforts.

Lydia Abad-Franch, the Chief Medical Officer of Sobi, expressed immense pride in continuing such a crucial commitment. She stated, "We are immensely proud to continue our contributions to the Humanitarian Aid Program of the World Federation of Hemophilia (WFH). Over 22,000 people with hemophilia have benefited from the factor donated by Sobi and Sanofi, and we look forward to the positive impact that will further unfold for those affected by these disorders."

The head of Global Medical Affairs for Rare Diseases at Sanofi, Alaa Hamed, reiterated this sentiment, emphasizing the two companies' goal to establish a consistent, sustainable program that addresses the outstanding needs in hemophilia care. He remarked, "This new agreement reinforces our dedication to advancing the standard of care for hemophilia globally. We are proud to continue this journey, ensuring that essential treatments for patients in developing countries improve their quality of life."

A Powerful Collaboration

The collaborative nature of this initiative was echoed by Cesar Garrido, the President of the World Federation of Hemophilia. He expressed gratitude for the contributions made by Sobi and Sanofi, pointing out how these efforts bring the global community closer to a vision of "Treatment for All." Mark Skinner, a board member at WFH USA, also highlighted the exceptional impact this program has made on countless lives, citing it as an inspiring model of how impactful partnerships in healthcare can be.

The Future of Hemophilia Care

As Sobi and Sanofi embark on this renewed five-year venture, the future looks promising for those diagnosed with hemophilia and other bleeding disorders. The WFH Humanitarian Aid Program plays a paramount role in addressing the gaps in access to necessary treatments, particularly in developing regions. By securing reliable and sustainable donations, the program ensures that patients receive continuous and effective care.

Moreover, the partnership is buttressed by a larger ecosystem that includes various contributors who share the goal of improving patient outcomes globally. The WFH works in tandem with national member organizations and healthcare professionals to enhance knowledge and tools that aid in the care of individuals with inherited bleeding disorders. Together, these organizations strive to redefine what is possible in the realm of treatment accessibility.

In conclusion, the renewed commitment by Sobi and Sanofi strengthens the ongoing fight against hemophilia and showcases the power of collaborative efforts. As they continue to work together, they pave the way for a brighter and healthier future for countless individuals affected by this condition.

For more information on the World Federation of Hemophilia and their initiatives, visit wfh.org.